$TCMD
TACTILE SYSTEMS TECHNOLOGY INC

2020 Q4 Form 10-K Financial Statement

#000155837021001465 Filed on February 23, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019 Q3
Revenue $59.24M $57.06M $49.61M
YoY Change 3.82% 22.85% 36.59%
Cost Of Revenue $30.11M $26.26M $14.24M
YoY Change 14.66% 4.04% 40.41%
Gross Profit $41.85M $41.10M $35.37M
YoY Change 1.83% 28.38% 35.11%
Gross Profit Margin 70.65% 72.03% 71.3%
Selling, General & Admin $20.76M $23.57M $30.71M
YoY Change -11.92% 32.94% 30.19%
% of Gross Profit 49.6% 57.35% 86.81%
Research & Development $1.370M $1.190M $1.467M
YoY Change 15.13% -11.19% 19.95%
% of Gross Profit 3.27% 2.9% 4.15%
Depreciation & Amortization $690.0K $960.0K $750.0K
YoY Change -28.13% -17.95% -3.85%
% of Gross Profit 1.65% 2.34% 2.12%
Operating Expenses $22.14M $24.75M $32.18M
YoY Change -10.55% 29.79% 29.68%
Operating Profit $6.991M $6.049M $3.203M
YoY Change 15.57% 183.19% 133.8%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.190M $150.0K $166.0K
YoY Change 693.33% 7.14% 29.69%
Pretax Income $8.180M $6.200M $3.363M
YoY Change 31.94% 173.13% 124.5%
Income Tax -$3.940M $1.920M $900.0K
% Of Pretax Income -48.17% 30.97% 26.76%
Net Earnings $12.11M $4.280M $2.431M
YoY Change 182.94% 81.36% 39.23%
Net Earnings / Revenue 20.44% 7.5% 4.9%
Basic Earnings Per Share $0.62 $0.23 $0.13
Diluted Earnings Per Share $0.61 $0.22 $0.12
COMMON SHARES
Basic Shares Outstanding 19.42M 19.03M 18.98M
Diluted Shares Outstanding 19.64M

Balance Sheet

Concept 2020 Q4 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.86M $45.23M $44.73M
YoY Change 5.79% -6.84% -2.54%
Cash & Equivalents $47.86M $22.77M $19.81M
Short-Term Investments $0.00 $22.46M $24.92M
Other Short-Term Assets $2.600M $2.500M $2.000M
YoY Change 4.0% 38.89% -16.67%
Inventory $18.56M $19.06M $16.88M
Prepaid Expenses
Receivables $43.85M $33.44M $27.68M
Other Receivables $0.00 $0.00 $3.800M
Total Short-Term Assets $123.6M $108.3M $102.7M
YoY Change 14.1% 27.51% 15.17%
LONG-TERM ASSETS
Property, Plant & Equipment $6.957M $7.408M $7.499M
YoY Change -6.09% 54.01% 82.9%
Goodwill
YoY Change
Intangibles $1.680M $5.312M $5.074M
YoY Change -68.37% -0.51%
Long-Term Investments
YoY Change
Other Assets $2.074M $1.658M $1.405M
YoY Change 25.09% 31.9% -68.07%
Total Long-Term Assets $50.47M $43.42M $41.05M
YoY Change 16.25% 96.37% 228.38%
TOTAL ASSETS
Total Short-Term Assets $123.6M $108.3M $102.7M
Total Long-Term Assets $50.47M $43.42M $41.05M
Total Assets $174.1M $151.8M $143.8M
YoY Change 14.72% 41.73% 41.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.197M $3.843M $6.289M
YoY Change 9.21% -24.79% 61.26%
Accrued Expenses $4.423M $4.498M $3.696M
YoY Change -1.67% 61.51% -65.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.71M $21.43M $24.13M
YoY Change 24.67% 33.29% 43.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $22.60M $17.70M $15.70M
YoY Change 27.68% 941.18% 881.25%
Total Long-Term Liabilities $22.62M $17.73M $15.68M
YoY Change 27.6% 927.77% 880.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.71M $21.43M $24.13M
Total Long-Term Liabilities $22.62M $17.73M $15.68M
Total Liabilities $49.34M $39.16M $39.81M
YoY Change 26.0% 119.97% 117.53%
SHAREHOLDERS EQUITY
Retained Earnings $20.06M $20.68M $16.39M
YoY Change -3.0% 113.04%
Common Stock $19.00K $19.00K $19.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $124.8M $112.6M $104.0M
YoY Change
Total Liabilities & Shareholders Equity $174.1M $151.8M $143.8M
YoY Change 14.72% 41.73% 41.37%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $12.11M $4.280M $2.431M
YoY Change 182.94% 81.36% 39.23%
Depreciation, Depletion And Amortization $690.0K $960.0K $750.0K
YoY Change -28.13% -17.95% -3.85%
Cash From Operating Activities $5.040M $90.00K $1.570M
YoY Change 5500.0% -98.31% -69.09%
INVESTING ACTIVITIES
Capital Expenditures -$500.0K -$1.560M -$2.570M
YoY Change -67.95% -74.47% 205.95%
Acquisitions
YoY Change
Other Investing Activities $0.00 $2.510M -$4.430M
YoY Change -100.0% -174.04% -521.9%
Cash From Investing Activities -$500.0K $950.0K -$7.000M
YoY Change -152.63% -110.0% -3281.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.110M 1.920M 200.0K
YoY Change -42.19% 68.42% -60.78%
NET CHANGE
Cash From Operating Activities 5.040M 90.00K 1.570M
Cash From Investing Activities -500.0K 950.0K -7.000M
Cash From Financing Activities 1.110M 1.920M 200.0K
Net Change In Cash 5.650M 2.960M -5.230M
YoY Change 90.88% -197.69% -190.02%
FREE CASH FLOW
Cash From Operating Activities $5.040M $90.00K $1.570M
Capital Expenditures -$500.0K -$1.560M -$2.570M
Free Cash Flow $5.540M $1.650M $4.140M
YoY Change 235.76% -85.58% -30.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
305000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseRightOfUseAsset
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityCurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2020Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityCurrent us-gaap:OperatingLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001027838
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19492718
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19152715
CY2019Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseRightOfUseAsset
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityCurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityCurrent us-gaap:OperatingLeaseLiabilityNoncurrent
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-37799
CY2020 dei Entity Registrant Name
EntityRegistrantName
Tactile Systems Technology, Inc.
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
3701 Wayzata Blvd, Suite 300
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55416
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1801204
CY2020 dei City Area Code
CityAreaCode
612
CY2020 dei Local Phone Number
LocalPhoneNumber
355-5100
CY2020 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.001 Per Share
CY2020 dei Trading Symbol
TradingSymbol
TCMD
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
772006579
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19507535
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47855000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22770000
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
22464000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43849000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33444000
CY2020Q4 us-gaap Net Investment In Lease
NetInvestmentInLease
10708000
CY2019Q4 us-gaap Net Investment In Lease
NetInvestmentInLease
8147000
CY2020Q4 us-gaap Inventory Net
InventoryNet
18563000
CY2019Q4 us-gaap Inventory Net
InventoryNet
19059000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2638000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2451000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
123613000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
108335000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6957000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7408000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20132000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15885000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1680000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5312000
CY2020Q4 tcmd Medicare Accounts Receivable Non Current
MedicareAccountsReceivableNonCurrent
9433000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20056000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20676000
CY2019Q4 tcmd Medicare Accounts Receivable Non Current
MedicareAccountsReceivableNonCurrent
4184000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10198000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8970000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2074000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1658000
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
50474000
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
43417000
CY2020Q4 us-gaap Assets
Assets
174087000
CY2019Q4 us-gaap Assets
Assets
151752000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4197000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3843000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11588000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10098000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4423000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4498000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2658000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
632000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2006000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1454000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1842000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
903000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26714000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21428000
CY2020Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3235000
CY2019Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
2541000
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
54000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19388000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15134000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
22623000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
17729000
CY2020Q4 us-gaap Liabilities
Liabilities
49337000
CY2019Q4 us-gaap Liabilities
Liabilities
39157000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19492718
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19152715
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104675000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91874000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
26000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
124750000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
112595000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174087000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
151752000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187130000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
189492000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
143751000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
54320000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
55256000
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
41493000
CY2020 us-gaap Gross Profit
GrossProfit
132810000
CY2019 us-gaap Gross Profit
GrossProfit
134236000
CY2018 us-gaap Gross Profit
GrossProfit
102258000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
79634000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
78920000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
60371000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5264000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5174000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5289000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51540000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39644000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33608000
CY2020 us-gaap Operating Expenses
OperatingExpenses
136438000
CY2019 us-gaap Operating Expenses
OperatingExpenses
123738000
CY2018 us-gaap Operating Expenses
OperatingExpenses
99268000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-3628000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
10498000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
2990000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1367000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
631000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
486000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2261000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11129000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3476000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1641000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3147000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-620000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10971000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6623000
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2019 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.58
CY2018 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.36
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2019 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.56
CY2018 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.34
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19346929
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18919007
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18252689
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19346929
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19641143
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19347632
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-620000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
10971000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
6623000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
31000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
60000
CY2020 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
5000
CY2019 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-3000
CY2018 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
24000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-26000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
34000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
36000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-646000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11005000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6659000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
72787000
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
7974000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1515000
CY2018 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-2379000
CY2018 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2714000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6659000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
89270000
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
9824000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2834000
CY2019 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-3391000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3053000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11005000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
112595000
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
10689000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1068000
CY2020 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1854000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2898000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-646000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
124750000
CY2020 us-gaap Profit Loss
ProfitLoss
-620000
CY2019 us-gaap Profit Loss
ProfitLoss
10971000
CY2018 us-gaap Profit Loss
ProfitLoss
6623000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2794000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3538000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3737000
CY2020 tcmd Amortization Of Premiums And Discounts On Securities Available For Sale
AmortizationOfPremiumsAndDiscountsOnSecuritiesAvailableForSale
-91000
CY2019 tcmd Amortization Of Premiums And Discounts On Securities Available For Sale
AmortizationOfPremiumsAndDiscountsOnSecuritiesAvailableForSale
-307000
CY2018 tcmd Amortization Of Premiums And Discounts On Securities Available For Sale
AmortizationOfPremiumsAndDiscountsOnSecuritiesAvailableForSale
-102000
CY2020 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1233000
CY2018 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
6182000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
10689000
CY2019 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
146000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9824000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7974000
CY2020 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
11000
CY2019 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-7000
CY2018 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-4000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4025000
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2534000
CY2019 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-1148000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10405000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9112000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6709000
CY2020 tcmd Increase Decrease In Net Investment In Lease
IncreaseDecreaseInNetInvestmentInLease
2561000
CY2019 tcmd Increase Decrease In Net Investment In Lease
IncreaseDecreaseInNetInvestmentInLease
8147000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-318000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7870000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
870000
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1972000
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2428000
CY2018 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-165000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
528000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1166000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1140000
CY2020 tcmd Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-559000
CY2019 tcmd Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-625000
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
5249000
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2300000
CY2018 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-834000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
337000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1389000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
690000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1490000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2677000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
715000
CY2020 tcmd Increase Decrease In Other Accrued Liabilities And Income Taxes Payable
IncreaseDecreaseInOtherAccruedLiabilitiesAndIncomeTaxesPayable
1308000
CY2019 tcmd Increase Decrease In Other Accrued Liabilities And Income Taxes Payable
IncreaseDecreaseInOtherAccruedLiabilitiesAndIncomeTaxesPayable
1729000
CY2018 tcmd Increase Decrease In Other Accrued Liabilities And Income Taxes Payable
IncreaseDecreaseInOtherAccruedLiabilitiesAndIncomeTaxesPayable
734000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2794000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2510000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9007000
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1493000
CY2018 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2000000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
22500000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
25000000
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
15000000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
22840000
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
21680000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2059000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20179000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2335000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14726000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5446000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4196000
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
232000
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
542000
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5350000
CY2020 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
30000
CY2018 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
500000
CY2020 tcmd Payment Of Taxes For Net Share Settlement Of Restricted Stock Units
PaymentOfTaxesForNetShareSettlementOfRestrictedStockUnits
1854000
CY2019 tcmd Payment Of Taxes For Net Share Settlement Of Restricted Stock Units
PaymentOfTaxesForNetShareSettlementOfRestrictedStockUnits
3391000
CY2018 tcmd Payment Of Taxes For Net Share Settlement Of Restricted Stock Units
PaymentOfTaxesForNetShareSettlementOfRestrictedStockUnits
2379000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1068000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2834000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1515000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2898000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3053000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2714000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2112000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2496000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1850000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
25085000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2671000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3869000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22770000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20099000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23968000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47855000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22770000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20099000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
9000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
543000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
344000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
2883000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
17000
CY2019 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
122000
CY2018 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
167000
CY2020 us-gaap Nature Of Operations
NatureOfOperations
<p style="background-color:#ffffff;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Note 1.  Nature of Business and Operations</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tactile Systems Technology, Inc. (“we,” “us,” and “our”) is the sole manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. We provide our products for use in the home and sell or rent them through vascular, wound and lymphedema clinics throughout the United States.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We were originally incorporated in Minnesota under the name Tactile Systems Technology, Inc. on January 30, 1995. During 2006, we established a merger corporation and subsequently, on July 21, 2006, merged with and into this merger corporation, resulting in us being reincorporated as a Delaware corporation. The resulting corporation assumed the name Tactile Systems Technology, Inc. In September 2013, we began doing business as “Tactile Medical.”</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On August 2, 2016, we closed the initial public offering of our common stock, which resulted in the sale of 4,120,000 shares of our common stock at a public offering price of $10.00 per share. We received net proceeds from the initial public offering of approximately $35.4 million, after deducting underwriting discounts and approximately $2.9 million of transaction expenses. In connection with the closing of the initial public offering, all of our outstanding redeemable convertible preferred stock automatically converted to common stock on August 2, 2016.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-bottom:12pt;text-align:justify;text-indent:36pt;margin:0pt;">Our business is affected by seasonality. In the first quarter of each year, when most patients have started a new insurance year and have not yet met their annual out-of-pocket payment obligations, we experience substantially reduced demand for our products. We typically experience higher revenue in the third and fourth quarters of the year when more patients have met their annual insurance deductibles, thereby reducing their out-of-pocket costs for our products, and because patients desire to exhaust their flexible spending accounts at year end. This seasonality applies only to purchases and rentals of our products by patients covered by commercial insurance and is not relevant to Medicare, Medicaid or the Veterans Administration, as those payers either do not have plans that have declining deductibles over the course of the plan year and/or do not have plans that include patient deductibles for purchases or rentals of our products.</p>
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and to disclose contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020 tcmd Proceeds From Grant From Relief Fund
ProceedsFromGrantFromReliefFund
1200000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
300000
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
700000
CY2020Q4 tcmd Percentage Of Claims Approved
PercentageOfClaimsApproved
0.90
CY2020 tcmd Medicare Receivables Time Period
MedicareReceivablesTimePeriod
P1Y
CY2020 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2020 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2019 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
22443000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
22000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
22464000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0
CY2020 tcmd Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
0
CY2020Q4 tcmd Marketable Securities In Unrealized Loss Position
MarketableSecuritiesInUnrealizedLossPosition
0
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
5997000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
5997000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1000
CY2020 tcmd Concentration Risk Number Of Insurance Companies
ConcentrationRiskNumberOfInsuranceCompanies
2
CY2019 tcmd Concentration Risk Number Of Insurance Companies
ConcentrationRiskNumberOfInsuranceCompanies
2
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7129000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6508000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
11434000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
12551000
CY2020Q4 us-gaap Inventory Net
InventoryNet
18563000
CY2019Q4 us-gaap Inventory Net
InventoryNet
19059000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14333000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12719000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7376000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5311000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6957000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7408000
CY2020 us-gaap Depreciation
Depreciation
2400000
CY2019 us-gaap Depreciation
Depreciation
3000000.0
CY2018 us-gaap Depreciation
Depreciation
3300000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1663000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
549000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1114000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2229000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
549000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1680000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5636000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
734000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4902000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6046000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
734000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5312000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
236000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
236000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
205000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
184000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
94000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
159000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1114000
CY2020 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P6Y3M18D
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1606000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1218000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
882000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
617000
CY2020Q4 tcmd In Transit Inventory Accrued Expense
InTransitInventoryAccruedExpense
634000
CY2019Q4 tcmd In Transit Inventory Accrued Expense
InTransitInventoryAccruedExpense
106000
CY2020Q4 tcmd Accrued Travel And Entertainment Current
AccruedTravelAndEntertainmentCurrent
545000
CY2019Q4 tcmd Accrued Travel And Entertainment Current
AccruedTravelAndEntertainmentCurrent
776000
CY2020Q4 tcmd Accrued Sales And Use Tax
AccruedSalesAndUseTax
193000
CY2019Q4 tcmd Accrued Sales And Use Tax
AccruedSalesAndUseTax
200000
CY2020Q4 tcmd Accrued Clinical Studies Expenses Current
AccruedClinicalStudiesExpensesCurrent
67000
CY2019Q4 tcmd Accrued Clinical Studies Expenses Current
AccruedClinicalStudiesExpensesCurrent
85000
CY2019Q4 tcmd Accrued Lease Termination Costs Current
AccruedLeaseTerminationCostsCurrent
1200000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
496000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
296000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4423000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4498000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3759000
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2566000
CY2020 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2957000
CY2019 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2576000
CY2020 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1875000
CY2019 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1383000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4841000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3759000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1606000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3759000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1218000
CY2020Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3235000
CY2019Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
2541000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4841000
CY2018Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000.0
CY2018Q3 tcmd Line Of Credit Facility Contingent Increase Additional Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAdditionalBorrowingCapacity
25000000.0
CY2018Q3 tcmd Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
35000000.0
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2020 tcmd Maximum Capital Expenditures During Fiscal Year Of Year One
MaximumCapitalExpendituresDuringFiscalYearOfYearOne
5000000.0
CY2020 tcmd Maximum Capital Expenditures During Fiscal Year Of Year Two
MaximumCapitalExpendituresDuringFiscalYearOfYearTwo
15000000.0
CY2020 tcmd Maximum Capital Expenditures During Fiscal Year Of Year Three
MaximumCapitalExpendituresDuringFiscalYearOfYearThree
15000000.0
CY2020 tcmd Maximum Capital Expenditures During Fiscal Year Of Year Four
MaximumCapitalExpendituresDuringFiscalYearOfYearFour
9000000.0
CY2018Q3 tcmd Debt Instrument Covenant Consolidated Leverage Ratio
DebtInstrumentCovenantConsolidatedLeverageRatio
3.00
CY2018Q3 tcmd Debt Instrument Covenant Minimum Cash And Cash Equivalents Balance
DebtInstrumentCovenantMinimumCashAndCashEquivalentsBalance
7500000
CY2018Q3 tcmd Debt Instrument Covenant Cash And Cash Equivalents Temporary Reduction
DebtInstrumentCovenantCashAndCashEquivalentsTemporaryReduction
5000000.0
CY2019 tcmd Lease Termination Fee
LeaseTerminationFee
1200000
CY2019 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-1100000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20132000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15885000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28716000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7322000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2006000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1454000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19388000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15134000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
21394000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16588000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M24D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y1M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.046
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
2646000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1799000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6789000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
18891000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2894000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2643000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2605000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2575000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2654000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
15345000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
21394000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2006000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19388000
CY2020Q4 tcmd Operating Lease Lease Not Yet Commenced Amount
OperatingLeaseLeaseNotYetCommencedAmount
7100000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
3000000.0
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
2100000
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1500000
CY2020Q4 tcmd Number Of Vendors
NumberOfVendors
2
CY2019Q4 tcmd Number Of Vendors
NumberOfVendors
2
CY2020Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
19500000
CY2016Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
5924453
CY2016Q3 tcmd Stock Issued During Period Prior To Completion Of Initial Offering Shares New Issues
StockIssuedDuringPeriodPriorToCompletionOfInitialOfferingSharesNewIssues
2354323
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4539
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10700000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9800000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8000000.0
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10689000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9824000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7974000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
12795000
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
14104000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187130000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
189492000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
143751000
CY2020 tcmd Percentage Of Revenue
PercentageOfRevenue
1
CY2019 tcmd Percentage Of Revenue
PercentageOfRevenue
1
CY2018 tcmd Percentage Of Revenue
PercentageOfRevenue
1
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187130000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
189492000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
143751000
CY2019 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
5000000.0
CY2020 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
25633000
CY2019 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
21570000
CY2020 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
9011000
CY2019 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
7510000
CY2020 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
16622000
CY2019 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
14060000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-833000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-653000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
205000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2416000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
294000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
100000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
778000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-359000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3194000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-303000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4804000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-395000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
153000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1537000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1228000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-150000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6341000
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-54000
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
3000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1641000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3147000
CY2020Q4 tcmd Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
5329000
CY2019Q4 tcmd Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
4137000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
312000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3179000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
3887000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
2589000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3558000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2393000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1489000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1239000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
1206000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
936000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
612000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
185000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
107000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
108000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16500000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14396000
CY2020Q4 tcmd Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
5016000
CY2019Q4 tcmd Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
3962000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1286000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1292000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
172000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6302000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5426000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
10198000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8970000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.079
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.073
CY2018 tcmd Effective Income Tax Rate Reconciliation Interest And Penalty Percent
EffectiveIncomeTaxRateReconciliationInterestAndPenaltyPercent
0.063
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.119
CY2020 tcmd Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
-0.055
CY2019 tcmd Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
0.091
CY2018 tcmd Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
0.118
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
-0.106
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
0.026
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
0.076
CY2020 tcmd Effective Income Tax Rate Reconciliation Incentive Stock Options
EffectiveIncomeTaxRateReconciliationIncentiveStockOptions
-0.004
CY2019 tcmd Effective Income Tax Rate Reconciliation Incentive Stock Options
EffectiveIncomeTaxRateReconciliationIncentiveStockOptions
0.002
CY2018 tcmd Effective Income Tax Rate Reconciliation Incentive Stock Options
EffectiveIncomeTaxRateReconciliationIncentiveStockOptions
0.019
CY2020 tcmd Effective Income Tax Rate Reconciliation Employee Stock Purchase Plan
EffectiveIncomeTaxRateReconciliationEmployeeStockPurchasePlan
-0.086
CY2019 tcmd Effective Income Tax Rate Reconciliation Employee Stock Purchase Plan
EffectiveIncomeTaxRateReconciliationEmployeeStockPurchasePlan
0.017
CY2018 tcmd Effective Income Tax Rate Reconciliation Excess Tax Benefit On Non Qualified Stock Options And Rsu
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitOnNonQualifiedStockOptionsAndRsu
-1.776
CY2020 tcmd Effective Income Tax Rate Reconciliation Interest And Penalty Percent
EffectiveIncomeTaxRateReconciliationInterestAndPenaltyPercent
0.019
CY2019 tcmd Effective Income Tax Rate Reconciliation Interest And Penalty Percent
EffectiveIncomeTaxRateReconciliationInterestAndPenaltyPercent
-0.002
CY2018 tcmd Effective Income Tax Rate Reconciliation Employee Stock Purchase Plan
EffectiveIncomeTaxRateReconciliationEmployeeStockPurchasePlan
0.045
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.080
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.017
CY2020 tcmd Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0.036
CY2019 tcmd Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
-0.004
CY2018 tcmd Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0.036
CY2020 tcmd Effective Income Tax Rate Reconciliation Internal Revenue Service Exam
EffectiveIncomeTaxRateReconciliationInternalRevenueServiceExam
0.025
CY2018 tcmd Effective Income Tax Rate Reconciliation Internal Revenue Service Exam
EffectiveIncomeTaxRateReconciliationInternalRevenueServiceExam
0.233
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.003
CY2020 tcmd Effective Income Tax Rate Reconciliation Federal Carryback Claim Percent
EffectiveIncomeTaxRateReconciliationFederalCarrybackClaimPercent
0.385
CY2020 tcmd Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits
EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
0.023
CY2018 tcmd Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits
EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
-0.046
CY2020 tcmd Effective Income Tax Rate Reconciliation Excess Tax Benefit On Non Qualified Stock Options And Rsu
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitOnNonQualifiedStockOptionsAndRsu
0.280
CY2019 tcmd Effective Income Tax Rate Reconciliation Excess Tax Benefit On Non Qualified Stock Options And Rsu
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitOnNonQualifiedStockOptionsAndRsu
-0.415
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.726
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.014
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.905
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
54000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
51000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
212000
CY2020 tcmd Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
-54000
CY2019 tcmd Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
3000
CY2018 tcmd Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
3477000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
3638000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
54000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
51000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-620000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10971000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6623000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19346929
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18919007
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18252689
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
722136
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1094943
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19346929
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19641143
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19347632
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1407983
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
387372
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
127848
CY2020Q4 tcmd Fair Value Transfers Within Three Level Hierarchy
FairValueTransfersWithinThreeLevelHierarchy
0
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43675000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35120000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49092000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59243000
CY2020Q1 us-gaap Gross Profit
GrossProfit
31073000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2020Q2 us-gaap Gross Profit
GrossProfit
24912000
CY2020Q3 us-gaap Gross Profit
GrossProfit
34972000
CY2020Q4 us-gaap Gross Profit
GrossProfit
41853000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4451000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7963000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1794000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
6991000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1307000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13850000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2424000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12113000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37617000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45200000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49612000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57063000
CY2019Q1 us-gaap Gross Profit
GrossProfit
26258000
CY2019Q2 us-gaap Gross Profit
GrossProfit
31505000
CY2019Q3 us-gaap Gross Profit
GrossProfit
35373000
CY2019Q4 us-gaap Gross Profit
GrossProfit
41100000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1802000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3048000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3203000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
6049000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1472000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2785000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2431000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4283000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22

Files In Submission

Name View Source Status
0001558370-21-001465-index-headers.html Edgar Link pending
0001558370-21-001465-index.html Edgar Link pending
0001558370-21-001465.txt Edgar Link pending
0001558370-21-001465-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcmd-20201231.xsd Edgar Link pending
tcmd-20201231x10k.htm Edgar Link pending
tcmd-20201231x10k005.jpg Edgar Link pending
tcmd-20201231x10k006.jpg Edgar Link pending
tcmd-20201231x10k007.jpg Edgar Link pending
tcmd-20201231x10k_htm.xml Edgar Link completed
tcmd-20201231xex23d1.htm Edgar Link pending
tcmd-20201231xex31d1.htm Edgar Link pending
tcmd-20201231xex31d2.htm Edgar Link pending
tcmd-20201231xex32d1.htm Edgar Link pending
tcmd-20201231xex32d2.htm Edgar Link pending
tcmd-20201231_cal.xml Edgar Link unprocessable
tcmd-20201231_def.xml Edgar Link unprocessable
tcmd-20201231_lab.xml Edgar Link unprocessable
tcmd-20201231_pre.xml Edgar Link unprocessable